Get App Open
In App
Credit Cards
Open App
you are here:

Mirae Asset Healthcare Fund - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 38.734 -0.74%
    (as on 14th October, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 99.89% investment in domestic equities of which 34.74% is in Large Cap stocks, 20.24% is in Mid Cap stocks, 9.11% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 14th October, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 07-Oct-25 10065.70 0.66% - -0.19% 33/236
1 Month 12-Sep-25 9863.00 -1.37% - -0.21% 184/237
3 Month 14-Jul-25 9892.50 -1.07% - 0.54% 160/229
6 Month 11-Apr-25 11062.70 10.63% - 13.47% 154/224
YTD 01-Jan-25 9756.70 -2.43% - 2.31% 147/213
1 Year 14-Oct-24 9780.60 -2.19% -2.19% -2.31% 85/195
2 Year 13-Oct-23 15045.30 50.45% 22.59% 17.97% 32/152
3 Year 14-Oct-22 17795.60 77.96% 21.16% 19.65% 46/127
5 Year 14-Oct-20 22070.70 120.71% 17.15% 21.97% 79/103
Since Inception 02-Jul-18 38734.00 287.34% 20.41% 12.04% 23/217

SIP Returns (NAV as on 14th October, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 14-Oct-24 12000 12419.99 3.5 % 6.55 %
2 Year 13-Oct-23 24000 27514.8 14.64 % 13.73 %
3 Year 14-Oct-22 36000 48614.48 35.04 % 20.5 %
5 Year 14-Oct-20 60000 92912.31 54.85 % 17.52 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Sep,2025)

Portfolio Turnover Ratio : 34.00%  |   Category average turnover ratio is 95.86%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 99.89% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.89%
No of Stocks : 30 (Category Avg - 44.42) | Large Cap Investments : 34.74%| Mid Cap Investments : 20.24% | Small Cap Investments : 9.11% | Other : 35.79%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 3195.6 11.57% 0.65% 12.5% (Apr 2025) 10.74% (Jul 2025) 20.04 L 90.00 k
Divis Laboratories Ltd. Pharmaceuticals 2143.1 7.76% -0.39% 8.53% (Jun 2025) 4.96% (Oct 2024) 3.77 L 5.00 k
Glenmark Pharmaceuticals Ltd. Pharmaceuticals 1925.5 6.97% 0.19% 7.24% (Jul 2025) 5.22% (Apr 2025) 9.86 L 0.00
Apollo Hospitals Enterprises Ltd. Hospital 1719.2 6.23% -0.09% 6.37% (Jun 2025) 4.82% (Dec 2024) 2.32 L 0.00
Cipla Ltd. Pharmaceuticals 1665.8 6.03% -0.27% 7.6% (Feb 2025) 6.03% (Sep 2025) 11.08 L 0.00
Lupin Ltd. Pharmaceuticals 1393.7 5.05% 0.10% 6.37% (Apr 2025) 4.94% (Jul 2025) 7.29 L 0.00
Aurobindo Pharma Ltd. Pharmaceuticals 1195.1 4.33% -1.69% 8.05% (Oct 2024) 4.33% (Sep 2025) 11.03 L -5.33 L
Dr. Reddys Laboratories Ltd. Pharmaceuticals 1158.2 4.19% -0.07% 6.38% (Dec 2024) 4.13% (Jul 2025) 9.46 L 0.00
Fortis Healthcare Ltd. Hospital 1157.1 4.19% 0.30% 4.19% (Sep 2025) 2.12% (Jan 2025) 11.93 L 0.00
Krishna Institute of Medical Sciences Ltd. Hospital 1033.2 3.74% -0.08% 4.32% (Nov 2024) 3.57% (Feb 2025) 14.76 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 0.25%
MF Units MF Units 0.01%
Net Receivables Net Receivables -0.15%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)

  • Standard Deviation

    Low volatility
    12.13vs12.57
    Category Avg
  • Beta

    Low volatility
    0.63vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.09vs1.01
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.21vs0.18
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    8.05vs3.66
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 406.67 -1.55 22.17 79.21 37.84 38.34
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 266.19 0.79 9.32 28.17 25.77 19.51
Nippon India Japan Equity Fund - Growth NA 289.73 -1.84 9.74 19.32 13.87 18.19
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8693.07 2.07 0.70 14.62 13.11 19.72
Nippon India US Equity Opportunities Fund - Growth NA 724.35 0.48 4.55 15.84 12.40 22.71
Franklin Asian Equity Fund - Growth NA 279.13 1.17 9.14 25.08 12.18 14.91
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1419.62 2.23 1.01 12.38 11.62 0.00
ITI Banking and Financial Services Fund - Regular Plan - Growth NA 311.03 2.81 -0.04 10.43 10.64 14.25
WhiteOak Capital Banking & Financial Services Fund - Regular Plan - Growth NA 483.64 0.97 0.11 11.85 10.35 0.00
Mirae Asset Banking and Financial Services Fund - Growth NA 2014.27 2.22 -0.10 12.47 9.98 18.39

More Funds from Mirae Asset Mutual Fund

Out of 102 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 4 is/are ranked 4 * , 4 is/are ranked 3 * , 6 is/are ranked 2 * , 1 is/are ranked 1 * , and 85 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Mirae Asset Large & Midcap Fund - Growth 2 40821.90 0.70 0.97 16.08 0.30 17.73
Mirae Asset Large Cap Fund - Regular - Growth 3 39615.50 -0.46 0.43 11.67 1.01 13.77
Mirae Asset ELSS Tax Saver Fund - Regular Plan - Growth 3 25910.64 0.47 0.53 15.06 1.71 18.02
Mirae Asset Midcap Fund - Regular Plan - Growth 2 17194.25 0.49 1.66 21.82 0.77 20.56
Mirae Asset Liquid Fund - Growth 4 11367.77 0.48 1.41 3.00 6.73 6.99
Mirae Asset Aggressive Hybrid Fund - Growth 2 9128.00 0.25 0.12 10.35 1.47 14.20
Mirae Asset Focused Fund - Growth 1 7769.11 -1.54 0.09 13.54 -0.84 12.66
Mirae Asset Great Consumer Fund - Growth NA 4632.32 -2.69 3.18 12.68 -5.52 17.64
Mirae Asset Nifty 50 ETF (MAN50ETF) 4 4489.56 0.12 0.56 11.06 1.28 14.76
Mirae Asset Nifty 50 ETF (MAN50ETF) 4 4489.56 0.12 0.56 11.06 1.28 14.76

Forum

+ See More